• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

家族性淀粉样多神经病患者足部自主神经支配评估。

Assessment of autonomic innervation of the foot in familial amyloid polyneuropathy.

机构信息

EA 4391, Faculté de Médecine, Université Paris Est Créteil, Créteil, France.

Service de Physiologie, Explorations Fonctionnelles, Unité de Neurophysiologie Clinique, Hôpital Henri Mondor, Assistance Publique - Hôpitaux de Paris, Créteil, France.

出版信息

Eur J Neurol. 2019 Jan;26(1):94-e10. doi: 10.1111/ene.13774. Epub 2018 Sep 12.

DOI:10.1111/ene.13774
PMID:30102818
Abstract

BACKGROUND AND PURPOSE

Distal involvement of autonomic nerve fibers is critical in familial amyloid polyneuropathy (FAP) due to transthyretin (TTR) mutation. This study compares different methods for assessing autonomic foot innervation in TTR-FAP patients.

METHODS

Three groups of seven TTR-FAP patients were included, according to disease severity: clinically asymptomatic, moderate or advanced neuropathy. The autonomic investigation included the eutectic mixture of local anesthetics test and laser Doppler flowmetry for vasomotor aspects and the Sudoscan® (measuring electrochemical skin conductance) and Neuropad® test for sudomotor aspects. Somatic innervation was assessed by performing nerve conduction studies, quantitative sensory testing [including vibration, cold and warm detection threshold (WDT) measurements] and laser evoked potentials.

RESULTS

The results of all neurophysiological tests varied according to TTR-FAP severity (P ≤ 0.01, Kruskal-Wallis test), except for the eutectic mixture of local anesthetics test and laser Doppler flowmetry variables. In addition, the sudomotor tests (Sudoscan or Neuropad) or WDT measurement provided early markers of neuropathy in two of the seven asymptomatic carriers. Finally, all neurophysiological results correlated with the Neuropathy Impairment Score (r values between -0.88 and -0.66, P < 0.005, Spearman test), except the cold detection threshold.

CONCLUSIONS

The Neuropad test could be used to detect TTR-FAP onset, but confirmation requires electrochemical skin conductance and WDT measurement. The Sudoscan technique, but not the Neuropad test (at least assessed at a fixed time point), could be valuable to follow the progression of the neuropathy. Follow-up investigation should also include large-fiber investigation (e.g. nerve conduction studies and vibration detection threshold). Conversely, reliable tests for assessing vasomotor disturbances in limb extremities of TTR-FAP patients are still awaited.

摘要

背景与目的

由于转甲状腺素蛋白(TTR)突变,自主神经纤维的远端受累在家族性淀粉样多神经病(FAP)中至关重要。本研究比较了评估 TTR-FAP 患者自主神经足部神经支配的不同方法。

方法

根据疾病严重程度,将三组共七名 TTR-FAP 患者纳入研究:临床无症状、中度或晚期神经病。自主神经检查包括局部麻醉剂混合物的 eutectic 试验和激光多普勒血流计进行血管运动方面的检查,以及 Sudoscan®(测量电化学皮肤电导)和 Neuropad®测试进行出汗方面的检查。躯体神经支配通过进行神经传导研究、定量感觉测试(包括振动、冷觉和温觉检测阈值(WDT)测量)和激光诱发电位来评估。

结果

除局部麻醉剂混合物试验和激光多普勒血流计变量外,所有神经生理测试的结果均根据 TTR-FAP 严重程度而变化(P≤0.01,Kruskal-Wallis 检验)。此外,在七名无症状携带者中的两名中,出汗测试(Sudoscan 或 Neuropad)或 WDT 测量提供了神经病的早期标志物。最后,所有神经生理结果均与神经病变损伤评分(r 值在-0.88 至-0.66 之间,P<0.005,Spearman 检验)相关,除冷觉检测阈值外。

结论

Neuropad 测试可用于检测 TTR-FAP 的发病,但需通过电化学皮肤电导和 WDT 测量来确认。Sudoscan 技术(至少在固定时间点评估)而非 Neuropad 测试可能对监测神经病的进展有价值。随访检查还应包括大纤维检查(例如神经传导研究和振动检测阈值)。相反,仍然需要可靠的测试来评估 TTR-FAP 患者肢体末端的血管运动障碍。

相似文献

1
Assessment of autonomic innervation of the foot in familial amyloid polyneuropathy.家族性淀粉样多神经病患者足部自主神经支配评估。
Eur J Neurol. 2019 Jan;26(1):94-e10. doi: 10.1111/ene.13774. Epub 2018 Sep 12.
2
The diagnostic accuracy of Sudoscan in transthyretin familial amyloid polyneuropathy.Sudoscan在转甲状腺素蛋白家族性淀粉样多神经病中的诊断准确性。
Clin Neurophysiol. 2016 May;127(5):2222-7. doi: 10.1016/j.clinph.2016.02.013. Epub 2016 Feb 27.
3
The value of electrochemical skin conductance measurement using Sudoscan® in the assessment of patients with familial amyloid polyneuropathy.应用 Sudoscan® 进行电化学皮肤电导测量在家族性淀粉样多发性神经病患者评估中的价值。
Clin Neurophysiol. 2018 Aug;129(8):1565-1569. doi: 10.1016/j.clinph.2018.05.005. Epub 2018 May 29.
4
Quantitative sudomotor test helps differentiate transthyretin familial amyloid polyneuropathy from chronic inflammatory demyelinating polyneuropathy.定量出汗测试有助于区分转甲状腺素蛋白家族性淀粉样多发性神经病与慢性炎症性脱髓鞘性多发性神经病。
Clin Neurophysiol. 2020 May;131(5):1129-1133. doi: 10.1016/j.clinph.2020.01.022. Epub 2020 Feb 21.
5
Diagnosis of small fiber neuropathy: A comparative study of five neurophysiological tests.小纤维神经病变的诊断:五种神经生理学检查的比较研究
Neurophysiol Clin. 2015 Dec;45(6):445-55. doi: 10.1016/j.neucli.2015.09.012. Epub 2015 Nov 17.
6
Neurophysiological markers of small fibre neuropathy in TTR-FAP mutation carriers.转甲状腺素蛋白淀粉样变性多发性神经病患者小纤维神经病的神经生理学标志物。
J Neurol. 2013 Jun;260(6):1497-503. doi: 10.1007/s00415-012-6816-8. Epub 2013 Jan 11.
7
Transthyretin familial amyloid polyneuropathy (TTR-FAP): Parameters for early diagnosis.转甲状腺素蛋白家族性淀粉样多发性神经病(TTR-FAP):早期诊断的参数。
Brain Behav. 2017 Dec 19;8(1):e00889. doi: 10.1002/brb3.889. eCollection 2018 Jan.
8
Follow-up in transthyretin familial amyloid polyneuropathy: Useful investigations.转甲状腺素蛋白家族性淀粉样多神经病的随访:有用的检查
J Neurol Sci. 2020 Jun 15;413:116776. doi: 10.1016/j.jns.2020.116776. Epub 2020 Mar 18.
9
Retrospective study of a TTR FAP cohort to modify NIS+7 for therapeutic trials.对转甲状腺素蛋白淀粉样变多发性神经病队列进行回顾性研究,以修改NIS+7用于治疗试验。
J Neurol Sci. 2014 Sep 15;344(1-2):121-8. doi: 10.1016/j.jns.2014.06.041. Epub 2014 Jun 27.
10
Characterization of Pain in Familial Amyloid Polyneuropathy.家族性淀粉样多神经病中的疼痛特征
J Pain. 2015 Nov;16(11):1106-14. doi: 10.1016/j.jpain.2015.07.010. Epub 2015 Aug 18.

引用本文的文献

1
Novel Pathogenic Variant c.258A>C, p.(Glu86Asp) in the Gene in a Bulgarian Patient with Hereditary Transthyretin Amyloidosis.保加利亚一名遗传性转甲状腺素蛋白淀粉样变性患者的基因中发现新型致病变异c.258A>C,p.(Glu86Asp) 。
Genes (Basel). 2025 Jun 22;16(7):726. doi: 10.3390/genes16070726.
2
From Sudoscan to bedside: theory, modalities, and application of electrochemical skin conductance in medical diagnostics.从Sudoscan到床边检测:电化学皮肤电导在医学诊断中的理论、方式及应用
Front Neuroanat. 2024 Oct 23;18:1454095. doi: 10.3389/fnana.2024.1454095. eCollection 2024.
3
Case Report: Transthyretin Glu54Leu-a rare mutation with predominant cardiac phenotype.
病例报告:转甲状腺素蛋白Glu54Leu——一种以心脏表型为主的罕见突变。
Front Cardiovasc Med. 2023 Oct 31;10:1228410. doi: 10.3389/fcvm.2023.1228410. eCollection 2023.
4
Nerve pathology of microangiopathy and thromboinflammation in hereditary transthyretin amyloidosis.遗传性转甲状腺素蛋白淀粉样变性的微血管病和血栓炎症的神经病理学。
Ann Clin Transl Neurol. 2024 Jan;11(1):30-44. doi: 10.1002/acn3.51930. Epub 2023 Oct 30.
5
Seven Years of Selective Genetic Screening Program and Follow-Up of Asymptomatic Carriers With Hereditary Transthyretin Amyloidosis in Bulgaria.保加利亚遗传性转甲状腺素蛋白淀粉样变性无症状携带者的七年选择性基因筛查计划及随访
Front Neurol. 2022 Apr 8;13:844595. doi: 10.3389/fneur.2022.844595. eCollection 2022.
6
Vagus nerve ultrasound in transthyretin familial amyloid polyneuropathy: A pilot study.转甲状腺素蛋白家族性淀粉样多发性神经病的迷走神经超声:一项初步研究。
J Neuroimaging. 2022 Mar;32(2):285-291. doi: 10.1111/jon.12956. Epub 2021 Dec 29.
7
Feasibility of assessing progression of transthyretin amyloid polyneuropathy using nerve conduction studies: Findings from the Transthyretin Amyloidosis Outcomes Survey (THAOS).评估转甲状腺素蛋白淀粉样多神经病进展的可行性:来自转甲状腺素蛋白淀粉样变性结局研究(THAOS)的结果。
J Peripher Nerv Syst. 2021 Jun;26(2):160-166. doi: 10.1111/jns.12444. Epub 2021 May 7.
8
Prevalence and prognostic value of autonomic neuropathy assessed by Sudoscan® in transthyretin wild-type cardiac amyloidosis.通过Sudoscan®评估的自主神经病变在转甲状腺素蛋白野生型心脏淀粉样变性中的患病率及预后价值。
ESC Heart Fail. 2021 Apr;8(2):1656-1665. doi: 10.1002/ehf2.13131. Epub 2020 Dec 22.
9
Circulating microRNAs Profile in Patients With Transthyretin Variant Amyloidosis.转甲状腺素蛋白变异型淀粉样变性患者的循环微小RNA谱
Front Mol Neurosci. 2020 Jun 23;13:102. doi: 10.3389/fnmol.2020.00102. eCollection 2020.
10
Instruments of Choice for Assessment and Monitoring Diabetic Foot: A Systematic Review.糖尿病足评估与监测的首选工具:一项系统综述
J Clin Med. 2020 Feb 24;9(2):602. doi: 10.3390/jcm9020602.